Total Funding
80
79
Total FundingPost-IPO Debt raised
Growth Score
-6 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
6693
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
- Ian Clements: Chief Financial Officer
- Alejandro Dorenbaum: Co-founder
About the Company
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome or ALGS. The company is also
involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Women Founded
